NASDAQ2391.28 (+0.09%)
S&P 5001165.82 (-0.03%)

Financial News Discussion of BSX - Boston Scientific Corporation on Squawk Box

Financial News for Boston Scientific Corporation (BSX)

BSX 3/18/2010 4:00PM 52 Week Price Range Market Capitalization Dividend Yield Recent Dividend
$7.07 $6.31 — $11.77 $10.5 Billion n/a n/a

Want to Sharpen Your Investing?

Learn how Ockham can help investors make informed decisions and slice through the noise. Learn more about Ockham's services.

Sign Up Now for Ockham's Stock Analysis and News Services

Explore Why Ockham?

Quality Analysis
Ockham has fundamental valuations on over 5000 companies which we distribute, to our clients via highly-focused equity reports, weekly newsletters, and analysts' daily market commentary blogs. (Learn More)
Crowd Sentiment
Through our partnership with The Motley Fool, Ockham provides the most robust data on investors' sentiment of individual stocks. This indicator, along with our valuations and our news tracking, helps our clients make informed investment decisions. (Learn More)
Financial News Slicing
With the influx of noise in our lives, it can be exceedingly difficult to separate the essential news from everything else. Ockham's RazorWire tool "slices" through business television and impactful blogs to provide you with the clearest information possible. (Learn More)
Boston Scientific Corp. was discussed on Squawk Box which was originally produced by CNBC on 2/17/2009
On 2/17/09 Boston Scientific Corporation was mentioned on Squawk Box. The exact context of the conversation can be found just below.

Boston Scientific Corporation is in the news. Find out how this impacts BSX trading on Ockham Research.

And it's bridge day in detroit. Can the auto marks make it to the starting line in time. >>> we recommend the sale of BOSTON SCIENTIFIC, almost two years ago at $18. We're changing our view down here at $8. We think it has earnings we think no one is paying it's in the strongest group in the market, which is in the medical device business. Bsx should be bought for better than expected quarter. It's speculation. Axis technologies, axys, that's unmanned cameras that see the bad guys. Use limits, please.

“ng it's in the strongest group in the market, which is in the medical device business. Bsx should be bought for better than expected quarter. It's speculation. Axis technologies, axys, that's unmanned cameras that see the bad guys. Use limits, please. ” Squawk Box Feb 17, 2009 6:35 AM
A couple other items to be aware of:
  • Between on Tuesday, February 17, 2009, when BSX was on Squawk Box, and now - shares of Boston Scientific Corporation have depreciated 22.73%.
  • Joe Kernen mentioned quite a few stocks, 19 individual companies to be exact. You can see the all company slices for Squawk Box on the recap page.
  • As far as Squawk Box on Tuesday, February 17, 2009, this is the only mention for Boston Scientific Corporation.
  • BSX has had 98 mentions, on various business television shows, since this one. Find out what was said with the latest financial news on Boston Scientific Corporation.
  • The most active stock on Squawk Box over the last 2 weeks has been Citigroup, Incorporated.